Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.37 |
| ▸ | CES1 | P23141 | 3/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CBFB | Q13951 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | F2RL1 | P55085 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1561647 | 0.85 | TAAR1 (0.36) | CES2CES1NR4A2GABRA1GABRG2 | |
| SCHEMBL4978674 | 0.82 | MEP1B (0.46) | NR4A2MEP1B | |
| SCHEMBL634584 | 0.82 | ALDH1A1 (0.36) | NR4A2TAAR1 | |
| SCHEMBL26615986 | 0.82 | CA3 (0.36) | CES2CES1GABRA1GABRG2GABRB3 | |
| SCHEMBL3310848 | 0.82 | CES2 (0.38) | CES2CES1GABRA1GABRG2GABRB3 | |
| SCHEMBL2064221 | 0.80 | CYP1A2 (0.33) | NR4A2MEP1B | |
| SCHEMBL13725020 | 0.80 | NR4A2 (0.33) | NR4A2CBFB | |
| SCHEMBL616685 | 0.80 | TAAR1 (0.41) | NR4A2TAAR1KMT2AGAA | |
| SCHEMBL1166843 | 0.80 | ENPP2 (0.33) | NR4A2GABRA1GABRG2GABRB3CYP4F2 | |
| SCHEMBL5425835 | 0.80 | CYP1A2 (0.33) | CES2CES1GABRA1GABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| WO-2010002175-A2 | RESIN COMPOSITION FOR CLADDING OF OPTICAL FIBER | SSCP CO., LTD. (KR) | 2010-01-07 | — | — | WO | claimed |
| US-20250313526-A1 | PYRETHROID COMPOUND CONTAINING DOUBLE BONDS AND CYANO GROUPS, SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF | JIANGSU YANGNONG CHEMICAL CO., LTD. (CN) | 2025-10-09 | — | — | US | disclosed |
| EP-4484407-A2 | (METH)ACRYLATE COMPOUND, ADDITIVE FOR OPTICAL RESIN, OPTICAL ELEMENT, AND OPTICAL DEVICE | NIKON CORPORATION (JP) | 2025-01-01 | — | — | EP | disclosed |
| CN-116082563-B | (Meth) acrylate compound, optical resin additive, optical element, and optical device | 株式会社 尼康 | 2024-09-20 | — | — | CN | disclosed |
| CN-118359760-A | Optical resin, optical element, and optical device | 株式会社 尼康 | 2024-07-19 | — | — | CN | disclosed |
| WO-2023160316-A1 | PYRETHROID COMPOUND CONTAINING DOUBLE BONDS AND CYANO GROUPS, SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF | 江苏扬农化工股份有限公司 | 2023-08-31 | — | — | WO | disclosed |
| CN-116375604-A | Double-bond cyano-containing pyrethroid compound, and synthetic method and application thereof | 江苏扬农化工股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-116082563-A | (meth) acrylate compound, optical resin additive, optical element, and optical device | 株式会社 尼康 | 2023-05-09 | — | — | CN | disclosed |
| US-11289238-B2 | Compositions for the filling of high aspect ratio vertical interconnect access (VIA) holes | HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC (US) | 2022-03-29 | — | — | US | disclosed |
| US-11142636-B2 | (Meth)acrylate compound, additive for optical resin, optical element, and optical device | NIKON CORPORATION (JP) | 2021-10-12 | — | — | US | disclosed |
| US-6022899-A | EFFECTIVE INHIBITORS OF THE CELLULAR SODIUM PROTON ANTIPORTER | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-02-08 | — | — | US | disclosed |
| US-5753710-A | INHIBITORS OF THE CELLULAR SODIUM PROTON ANTIPORTER | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-05-19 | — | — | US | disclosed |
| EP-0748795-A2 | Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-12-18 | — | — | EP | disclosed |
| US-5340835-A | Insecticides | ROUSSEL-UCLAF (FR) | 1994-08-23 | — | — | US | disclosed |
| US-5336670-A | 2,2-dimethyl-3-(but-1-en-3-ynyl)-cyclopropane carboxylates | ROUSSEL-UCLAF (FR) | 1994-08-09 | — | — | US | disclosed |
| US-4935420-A | MICROBIOCIDES, ANTISEPTICS | OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-06-19 | — | — | US | disclosed |
| US-4880806-A | BACTERICIDES | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1989-11-14 | — | — | US | disclosed |
| US-4874764-A | ANTIMICROBIALS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1989-10-17 | — | — | US | disclosed |
| US-4855292-A | ANTIMICROBIAL AGENTS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1989-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313526-A1 | PYRETHROID COMPOUND CONTAINING DOUBLE BONDS AND CYANO GROUPS, SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF | NOTUM, DDT, CYP4F11 | CES2 482/4885CES1 233/4885NR4A2 2879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.